Adam Hayet
About Adam Hayet
Adam Hayet is a finance manager at BridgeBio, overseeing budget management and reforecasting for Gene Therapy affiliates. He has a background in financial analysis and holds an M.B.A. from Loyola University Maryland.
Current Role at BridgeBio
Adam Hayet serves as the Manager of Finance at BridgeBio, a position he has held since 2020. In this role, he manages the budget and reforecasting processes for the Gene Therapy affiliates. He is responsible for overseeing the monthly Budget vs. Actual (BVA) process across multiple departments within the Gene Therapy division. Additionally, he acts as the financial owner of Gene Therapy CDMO agreements, ensuring financial compliance and effective resource allocation.
Previous Experience at Aerotek
Prior to his current role, Adam Hayet worked at Aerotek from 2012 to 2018. He held two positions during his tenure: Business Operations Associate from 2012 to 2014 and Project Analyst from 2014 to 2018. In these roles, he contributed to various operational and analytical projects, gaining valuable experience in finance and project management.
Experience at Catalent Pharma Solutions
Adam Hayet was employed at Catalent Pharma Solutions from 2018 to 2020 as a Senior Financial Analyst. In this capacity, he focused on financial analysis and reporting, further developing his expertise in finance within the pharmaceutical industry. His work contributed to the financial oversight and strategic planning efforts at the company.
Education and Expertise
Adam Hayet holds a Master of Business Administration (M.B.A.) from Loyola University Maryland, where he studied Management from 2016 to 2020. He also earned a Bachelor of Business Administration in Marketing from Towson University, studying from 2008 to 2012. His educational background provides a solid foundation for his roles in finance and management.